Wuhan Healthgen Biotechnology Corp. (SHA:688765)

SHA:688765 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	132.37	160.4	235.97	387.56	243.41	150.71
Cash & Short-Term Investments	132.37	160.4	235.97	387.56	243.41	150.71
Cash Growth	-43.91%	-32.02%	-39.11%	59.22%	61.51%	950.02%
Accounts Receivable	6.36	0.14	0.2	0.09	0.02	0.02
Other Receivables	0.98	0.35	0.35	0.29	0.77	0.17
Receivables	7.34	0.49	0.55	0.38	0.79	0.19
Inventory	80.63	50.02	35.73	25.66	12.52	13.37
Other Current Assets	41.24	26.43	16.42	34.78	26.49	5.81
Total Current Assets	261.58	237.34	288.67	448.38	283.21	170.07
Property, Plant & Equipment	841.2	733.42	606.23	580.78	208.24	43.24
Other Intangible Assets	85.72	87.39	66.24	68.08	24.53	26.23
Long-Term Deferred Charges	3.2	3.56	0.07	-	-	-
Other Long-Term Assets	125.56	0.1	0.99	5.43	77.16	0.17
Total Assets	1,317	1,062	962.2	1,103	593.13	239.71
Accounts Payable	199.27	175.9	105.77	169.84	122.1	5.58
Accrued Expenses	4.98	9.06	9.56	7.88	6.05	5.7
Short-Term Debt	15.01	10.01	-	-	-	0.1
Current Portion of Long-Term Debt	-	-	1.07	1.02	-	0.31
Current Portion of Leases	-	-	0.29	0.55	0.37	-
Current Unearned Revenue	2.4	2.45	1.92	2.44	1.1	5.14
Other Current Liabilities	51.14	35.24	2.09	9.09	2.02	1.12
Total Current Liabilities	272.79	232.67	120.7	190.82	131.63	17.95
Long-Term Debt	470.79	184	90.12	13.13	-	9.6
Long-Term Leases	19.47	19.29	2.45	0.54	0.39	-
Long-Term Unearned Revenue	21.81	23.02	15.83	1.43	1.79	3.93
Other Long-Term Liabilities	1.49	1.49	1.49	1.49	-	-
Total Liabilities	786.35	460.46	230.58	207.41	133.81	31.48
Common Stock	268.05	268.05	268.05	268.05	239.13	55.89
Additional Paid-In Capital	1,196	1,185	1,164	1,140	589.64	387.76
Retained Earnings	-932.99	-851.36	-699.99	-513.03	-369.45	-235.42
Shareholders' Equity	530.91	601.35	731.62	895.26	459.32	208.23
Total Liabilities & Equity	1,317	1,062	962.2	1,103	593.13	239.71
Total Debt	505.27	213.3	93.93	15.25	0.76	10.01
Net Cash (Debt)	-372.9	-52.89	142.04	372.31	242.65	140.69
Net Cash Growth	-	-	-61.85%	53.44%	72.47%	5104.02%
Net Cash Per Share	-1.38	-0.20	0.53	1.43	1.12	2.82
Filing Date Shares Outstanding	272.09	269.59	268.05	261.05	268.05	49.86
Total Common Shares Outstanding	272.09	269.59	268.05	261.05	239.13	49.86
Working Capital	-11.22	4.68	167.97	257.57	151.58	152.12
Book Value Per Share	1.95	2.23	2.73	3.43	1.92	4.18
Tangible Book Value	445.19	513.96	665.38	827.18	434.8	182.01
Tangible Book Value Per Share	1.64	1.91	2.48	3.17	1.82	3.65

Source: S&P Global Market Intelligence. Standard template. Financial Sources.